Alao, Richel Mae .
HRN: 04-32-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2025
AMPICILLIN 1GM (VIAL)
04/27/2025
05/03/2025
IV
2g
Q6
G1P0 PU 39 0/7 Weeks AOG By LMP; PROM X 15hrs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes